0001104659-21-151214.txt : 20211217
0001104659-21-151214.hdr.sgml : 20211217
20211217170235
ACCESSION NUMBER: 0001104659-21-151214
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211215
FILED AS OF DATE: 20211217
DATE AS OF CHANGE: 20211217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Almenoff June Sherie
CENTRAL INDEX KEY: 0001492647
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36641
FILM NUMBER: 211502424
MAIL ADDRESS:
STREET 1: C/O BRAINSTORM CELL THERAPEUTICS INC.
STREET 2: 1325 AVENUE OF AMERICAS 28TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRAINSTORM CELL THERAPEUTICS INC.
CENTRAL INDEX KEY: 0001137883
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 207273918
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1325 AVENUE OF AMERICAS
STREET 2: 28TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 201-488-0460
MAIL ADDRESS:
STREET 1: 1325 AVENUE OF AMERICAS
STREET 2: 28TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: BRAINSTORM CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 20041122
FORMER COMPANY:
FORMER CONFORMED NAME: GOLDEN HAND RESOURCES INC
DATE OF NAME CHANGE: 20030827
FORMER COMPANY:
FORMER CONFORMED NAME: WIZBANG TECHNOLOGIES INC
DATE OF NAME CHANGE: 20010409
4
1
tm2135659-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-15
0
0001137883
BRAINSTORM CELL THERAPEUTICS INC.
BCLI
0001492647
Almenoff June Sherie
C/O BRAINSTORM CELL THERAPEUTICS INC.
1325 AVENUE OF THE AMERICAS, 28TH FLOOR
NEW YORK
NY
10019
1
0
0
0
Common Stock
2021-12-15
4
A
0
2000
0
A
6000
D
Common Stock
7175
I
By Meadowlark Management LLC
Shares acquired are shares of restricted stock awarded in connection with the Company's 2021 Annual Meeting of Stockholders pursuant to the Company's Second Amended and Restated Director Compensation Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on January 15, 2022 until fully vested on the first anniversary of December 15, 2021.
The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.
/s/ June Sherie Almenoff
2021-12-17